Celebrating 15 years
of driving innovation
for Life Sciences in Europe


The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) is Europe’s trade body that gives a bigger voice to small and mid-sized innovative companies working in the field of biopharmaceuticals and medical technologies. Through its members, EUCOPE represents 2600+ biopharmaceutical companies that are researching, designing, developing, supplying, manufacturing, and deploying the next generation of pharmaceutical innovation and therapeutic solutions around the continent.

Based in Brussels, Belgium, EUCOPE’s commitment is to lead and engage in partnerships spanning the entire medicine lifecycle to find actionable solutions that benefit our members, the patients they serve, and healthcare systems overall. As a trade association, we advocate for sound public policy that supports innovation, while fostering a community built on a shared purpose: improving and saving the lives of European patients through ground-breaking therapies and medical technology. We provide a platform for discussion on major healthcare topics and developments, provide ad hoc expertise and updates on national market access and HTA issues and ensure that our members’ voices are heard first in the early stages of policy-making and legislative procedures.

Read more…

Upcoming Events


17. April 2023 — Website

Nordic Rare Disease Summit 2023

On April 17, 2023, the Nordic Rare Disease Summit will bring together experts and decision makers, building on the success of the first Nordic Rare Disease Summit in 2021. The Summit will be organised during the Swedish Presidency of the Council of the European Union…. read more


24. April 2023 to 25. April 2023 — Register Here

The Economist’s Cell & Gene Therapy Summit 2023

April 24th – 25th 2023 • Radisson Collection Hotel, Grand Place Brussels. Simplify the conversation around the advancement of cell and gene products in the market Under the stewardship of The Economist editors, our inaugural event on cell and gene therapies convenes industry stakeholders to… read more


23. May 2023 to 25. May 2023 — Register Here

World Orphan Drug Congress USA

The World Orphan Drug Congress brings together leading pharmaceutical and biotech companies, government and regulatory authorities, patient advocacy groups, payers, investors and solution providers. The conference is a place to meet and brainstorm ways to advance orphan drug development and improve access to life-saving therapies…. read more


25. May 2023 to 26. May 2023 — Register Here

Pharma Partnering Summit

The Pharma Partnering Summit is an exclusive Life Sciences Industry event, with the aim to help companies expand their network and put together licensing deals, research collaborations and financing. Our platform brings together senior executives from different parts of the world specialising in Business Development… read more


5. June 2023 to 8. June 2023 — Register Here

BIO International Convention

The BIO International Convention attracts thousands of biotechnology and pharma leaders who come together for one week of intensive networking to discover new opportunities and promising partnerships. As is tradition, we invite you to join flanders.bio and Flanders Investment & Trade at the Belgian Pavilion during the largest global event for… read more

News & Updates

EUCOPE Member Spotlight: Q&A with Avanzanite Bioscience

Every month, EUCOPE spotlights a member company and the great work they’re doing to advance the life sciences industry and drive innovation to serve patients better. In March, we spoke with Adam Plich, Founder and CEO of Avanzanite Bioscience B.V. Adam Andrzej Plich is the… read more

New date for pharmaceutical legislation proposal set for 26 April

After announcing the delay from the 29 March deadline, the European Commission is now expected to publish its proposal to revise the European Union’s pharmaceutical legislation on April 26, according to an agenda of Commission meetings published on 28 March 2023. Before the announcement, EU… read more

OD Expert Group launches its policy proposals for the OMP Revision in a workshop in Parliament

On March 22, in a workshop in the European Parliament hosted by MEP Weiss, the OD Expert Group presented its Policy Proposals for the revision of the OMP Regulation. Thanks to everyone who participated in the event, whether in-person or remotely .  The OD Expert… read more

EMA pilots scientific advice for certain high-risk medical devices

The European Medicines Agency (EMA) has launched a pilot to give scientific advice on the intended clinical development strategy and proposals for clinical investigation for certain high-risk medical devices (all class III devices and class IIb active devices intended to administer and/or remove medicinal product(s)). As of… read more

Position Paper on Real World Evidence (RWE) across lifecycle of ATMPs

The past 20 years have seen the gradual launch of advanced therapy medicinal products (ATMPs), in the EU, presenting patients with treatment options where, in some cases, no previous treatments were available. This pace in innovation is not expected to slow down, with five gene… read more

Council & Parliament adopted amendment to the MDR / IVDR

On 7 March, the Council of the EU has officially adopted the amendment to the MDR and IVDR. This follows the positive vote from the European Parliament last month and paves the way for the formal signature of the legislative text, which is scheduled for… read more

🎙️Sounds of Science Podcast #14 on Trans-Atlantic Innovation

Sounds of Science Podcast – Episode 14 Trans-Atlantic Innovation : Building bridges between the EU and US life sciences industry With the passing of the Inflation Reduction Act, significant changes are coming for drug pricing and payment in the United States. At the same time,… read more

🎙️Sounds of Science #13 on Rare Disease Day 2023

Sounds of Science Podcast – Episode 13 Rare Disease Day 2023: Improving equitable access and diagnosis for people living with a rare disease Between 27 and 36 million Europeans experience living with a rare disease. Every Rare Disease Day – taking place on 28 February… read more

EUCOPE Member Spotlight: Q&A with BioCryst

Every month, EUCOPE spotlights a member company and the great work they’re doing to advance the life sciences industry and drive innovation to serve patients better. In February, we spoke with Sandra Nestler-Parr, Vice President, Value & Access, BioCryst Pharmaceuticals.  Sandra Nestler-Parr is Vice President… read more

Launch of the Nordic Rare Disease Summit 2023

There is momentum for change. Join us to discuss how to make that change happen! The challenges we are facing today within rare diseases are complex and extensive. To understand and overcome these, we need to work together and share knowledge across countries, between expert… read more

Interested in becoming a member?

EUCOPE gives voice to small to medium-sized innovative companies active in the field of pharmaceuticals, biotechnologies, and medical technologies at the European level. Learn more about the benefits of membership with EUCOPE.

Benefits of membership